The MMS works with the Massachusetts congressional delegation, national medical associations, and federal regulators to produce results for patients and physicians in Massachusetts and across the country.
Comments to Centers for Medicare & Medicaid Services Regarding Calendar Year 2024 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule
September 11, 2023
Comments to DEA Regarding Buprenorphine Telehealth Regulation
March 31, 2023
Comments to CMS on NPRM to Advance Interoperability and Improve Prior Authorization
March 13, 2023
Comments on 2023 Medicare Physician Fee Schedule
September 6, 2022
Comments to FDA on Menthol Cigarettes and Flavored Cigars
August 2, 2022
Comments to CMS on Provider Burden Due to Federal Price Transparency Rules
March 7, 2022
Comments to HHS, DOL and USDT on Requirements Relative to Surprise Billing, Part 2
December 6, 2021
Comments to CMS on the 2022 Medicare Physician Fee Schedule
September 13, 2021
Comments to CMS on Requirements Related to Surprise Billing, Part 1
September 7, 2021
Comments to CMS on Prior Authorization and Provider Burden Proposed Rule
January 4, 2021
